{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:29:08Z","timestamp":1793089748672,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jsbmb.2025.106816","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T11:39:30Z","timestamp":1750073970000},"page":"106816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Research progress of lipid metabolism reprogramming and related drug therapy in ovarian cancer"],"prefix":"10.1016","volume":"253","author":[{"given":"Xiangyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8073-6450","authenticated-orcid":false,"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022 [J]","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian cancer: an integrated review [J]","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.jsbmb.2025.106816_bib3","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression [J]","volume":"368","author":"Faubert","year":"2020","journal-title":"Science (New York NY)"},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106816_bib4","first-page":"9950","article-title":"Metabolic reprogramming in epithelial ovarian cancer [J]","volume":"13","author":"Nantasupha","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jsbmb.2025.106816_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors [J]","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106816_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121605","article-title":"The role of CD36 in cancer progression and its value as a therapeutic target [J]","volume":"12","author":"Feng","year":"2023","journal-title":"Cells"},{"issue":"7754","key":"10.1016\/j.jsbmb.2025.106816_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer [J]","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.jsbmb.2025.106816_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212198","article-title":"A possible role for HMG-CoA reductase inhibitors and its association with HMGCR genetic variation in Parkinson's disease [J]","volume":"22","author":"Pierzchli\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106816_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.2020.0150","article-title":"Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer [J]","volume":"323","author":"Yarmolinsky","year":"2020","journal-title":"Jama"},{"issue":"15","key":"10.1016\/j.jsbmb.2025.106816_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153727","article-title":"Evaluating targeted therapies in ovarian cancer metabolism: novel role for PCSK9 and second generation mTOR inhibitors [J]","volume":"13","author":"Jacome Sanz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2025.106816_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2022.07.007","article-title":"Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: structure-activity relationship and mechanism of action [J]","volume":"128","author":"Zuhra","year":"2022","journal-title":"Nitric Oxide Biol. Chem."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106816_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050697","article-title":"Cystathionine-\u03b2-synthase: molecular regulation and pharmacological inhibition [J]","volume":"10","author":"Zuhra","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jsbmb.2025.106816_bib13","article-title":"Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-\u03b1\/VEGF pathway [J]","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jsbmb.2025.106816_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102466","article-title":"Regulation of CyR61 expression and release by 3-mercaptopyruvate sulfurtransferase in colon cancer cells [J]","volume":"56","author":"ASCEN\u00e7\u00e3O","year":"2022","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/mmr.2013.1505","article-title":"TOFA suppresses ovarian cancer cell growth in vitro and in vivo [J]","volume":"8","author":"Li","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jsbmb.2025.106816_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102331","article-title":"Emerging roles of cystathionine \u03b2-synthase in various forms of cancer [J]","volume":"53","author":"ASCEN\u00e7\u00e3O","year":"2022","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106816_bib17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.31392","article-title":"The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model [J]","volume":"143","author":"Papaevangelou","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12964-023-01297-9","article-title":"Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis [J]","volume":"21","author":"Wang","year":"2023","journal-title":"Cell communication signaling CCS"},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106816_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004616","article-title":"Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating \u03b2-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody [J]","volume":"10","author":"Katoh","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106816_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge [J]","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.jsbmb.2025.106816_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217280","article-title":"Targeted inhibition of CHK\u03b1 and mTOR in models of pancreatic ductal adenocarcinoma: a novel regimen for metastasis [J]","volume":"605","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41467-022-29137-3","article-title":"Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion [J]","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","article-title":"Metabolomic rewiring promotes endocrine therapy resistance in breast cancer [J]","volume":"84","author":"Ahn","year":"2024","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7150\/thno.65098","article-title":"Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization [J]","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106816_bib25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00432-022-03957-8","article-title":"CD36: an emerging therapeutic target for cancer and its molecular mechanisms [J]","volume":"148","author":"Ruan","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.jsbmb.2025.106816_bib26","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis [J]","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.jsbmb.2025.106816_bib27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.21037\/atm-21-3026","article-title":"Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments [J]","volume":"9","author":"Chen","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jsbmb.2025.106816_bib28","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.2147\/CMAR.S337873","article-title":"Low density lipoprotein receptor (LDLR) and 3-hydroxy-3-methylglutaryl coenzyme a reductase (HMGCR) expression are associated with platinum-resistance and prognosis in ovarian carcinoma patients [J]","volume":"13","author":"Huang","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106816_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040828","article-title":"Cholesterol homeostasis modulates platinum sensitivity in human ovarian cancer [J]","volume":"9","author":"Criscuolo","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2008.10.027","article-title":"Degradation of LDLR protein mediated by 'gain of function' PCSK9 mutants in normal and ARH cells [J]","volume":"203","author":"FASANO","year":"2009","journal-title":"Atherosclerosis"},{"issue":"35","key":"10.1016\/j.jsbmb.2025.106816_bib31","doi-asserted-by":"crossref","first-page":"37367","DOI":"10.18632\/oncotarget.5424","article-title":"Role of cystathionine beta synthase in lipid metabolism in ovarian cancer [J]","volume":"6","author":"Chakraborty","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.jsbmb.2025.106816_bib32","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/00029330-200611020-00006","article-title":"Localization of cystathionine beta synthase in mice ovaries and its expression profile during follicular development [J]","volume":"119","author":"Liang","year":"2006","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106816_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.mehy.2013.06.009","article-title":"Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism? [J]","volume":"81","author":"Hu","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41419-020-03336-6","article-title":"MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS\/AKT\/mTOR signaling pathway [J]","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106816_bib35","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.7150\/ijbs.56477","article-title":"Aurka deficiency in the intestinal epithelium promotes age-induced obesity via propionate-mediated AKT activation [J]","volume":"17","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bjc.2012.246","article-title":"Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas [J]","volume":"107","author":"Rahman","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106816_bib37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00404-018-4841-2","article-title":"Orlistat induces apoptosis and protective autophagy in ovarian cancer cells: involvement of Akt-mTOR-mediated signaling pathway [J]","volume":"298","author":"Peng","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13048-021-00886-x","article-title":"Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics [J]","volume":"14","author":"Franz","year":"2021","journal-title":"J. Ovarian Res."},{"issue":"20","key":"10.1016\/j.jsbmb.2025.106816_bib39","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death [J]","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2013.08.041","article-title":"Extracellular lipid metabolism influences the survival of ovarian cancer cells [J]","volume":"439","author":"Kuwata","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2025.106816_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150005","article-title":"PPAR-\u03b1 inhibits DHEA-induced ferroptosis in granulosa cells through upregulation of FADS2 [J]","volume":"715","author":"Liu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"10.1016\/j.jsbmb.2025.106816_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205251","article-title":"Lipid droplet accumulation independently predicts poor clinical prognosis in high-grade serous ovarian carcinoma [J]","volume":"13","author":"Iwahashi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2025.106816_bib43","doi-asserted-by":"crossref","unstructured":"Yawei Leng, 2024, The oncogenic role and regulatory mechanism of ACAA2 in human ovarian cancer [D].","DOI":"10.1002\/mc.23729"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13000-023-01435-4","article-title":"High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer [J]","volume":"19","author":"Wang","year":"2024","journal-title":"Diagn. Pathol."},{"issue":"4-6","key":"10.1016\/j.jsbmb.2025.106816_bib45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.plefa.2010.02.005","article-title":"Lipid droplets in inflammation and cancer [J]","volume":"82","author":"Bozza","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106816_bib46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4252\/wjsc.v13.i9.1307","article-title":"Lipid droplets as metabolic determinants for stemness and chemoresistance in cancer [J]","volume":"13","author":"Royo-garc\u00eda","year":"2021","journal-title":"World J. Stem Cells"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106816_bib47","article-title":"Lipid droplets in cancer: guardians of fat in a stressful world [J]","volume":"23","author":"Petan","year":"2018","journal-title":"Mol. (Basel Switz.)"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106816_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets [J]","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106816_bib49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41419-022-05291-w","article-title":"DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHK\u03b1 to disrupt choline metabolism [J]","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jsbmb.2025.106816_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jnci\/dju149","article-title":"ABCA transporter gene expression and poor outcome in epithelial ovarian cancer [J]","volume":"106","author":"Hedditch E L","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"17","key":"10.1016\/j.jsbmb.2025.106816_bib51","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.7150\/jca.20766","article-title":"Gene expression profiling reveals novel candidate markers of ovarian carcinoma intraperitoneal metastasis [J]","volume":"8","author":"Elsnerova","year":"2017","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106816_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121601","article-title":"Rewiring of lipid metabolism and storage in ovarian cancer cells after anti-VEGF therapy [J]","volume":"8","author":"Curtarello","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106816_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","article-title":"Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation [J]","volume":"28","author":"Raud","year":"2018","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106816_bib54","article-title":"Lipid alterations in chronic liver disease and liver cancer [J]","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","article-title":"Cancer lipid metabolism confers antiangiogenic drug resistance [J]","volume":"28","author":"Iwamoto","year":"2018","journal-title":"Cell Metab."},{"issue":"15","key":"10.1016\/j.jsbmb.2025.106816_bib56","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.7150\/ijbs.64714","article-title":"Targeted inhibition of LPL\/FABP4\/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer [J]","volume":"17","author":"YANG","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106816_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101023","article-title":"CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS\/NF\u03baB pathway in ovarian cancer [J]","volume":"14","author":"Zhang","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jsbmb.2025.106816_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2021.04.023","article-title":"Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer [J]","volume":"511","author":"Ligorio","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106816_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2016.11.001","article-title":"Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: a single institution retrospective review [J]","volume":"144","author":"Marchetti","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.jsbmb.2025.106816_bib60","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment [J]","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106816_bib61","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth [J]","volume":"17","author":"NiemaN","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jsbmb.2025.106816_bib62","article-title":"Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer [J]","volume":"174","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106816_bib63","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.31557\/APJCP.2022.23.5.1699","article-title":"Metabolic reprogramming and lipophagy mediates survival of ascites derived metastatic ovarian cancer cells [J]","volume":"23","author":"S S K","year":"2022","journal-title":"Asian Pacific J. Cancer Prev. APJCP"},{"issue":"38","key":"10.1016\/j.jsbmb.2025.106816_bib64","doi-asserted-by":"crossref","first-page":"62019","DOI":"10.18632\/oncotarget.11495","article-title":"Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition [J]","volume":"7","author":"Lobello","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106816_bib65","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells [J]","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jsbmb.2025.106816_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147515","article-title":"Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity [J]","volume":"876","author":"Dong","year":"2023","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis [J]","volume":"22","author":"Lee","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106816_bib68","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways [J]","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106816_bib69","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.3390\/ijms23126857","article-title":"Orchestrated Action of AMPK Activation and Combined VEGF\/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers [J]","volume":"23","author":"Yung","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602500144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602500144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:32:00Z","timestamp":1751614320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007602500144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":69,"alternative-id":["S096007602500144X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106816","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress of lipid metabolism reprogramming and related drug therapy in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106816"}}